Results for tag: "Peptic Ulcer Hemorrhage Drug"

The Peptic Ulcer Hemorrhage Drug market is a subset of the Cardiovascular Drugs market. It is composed of drugs used to treat peptic ulcers, which are sores in the lining of the stomach or small intestine. These drugs are used to reduce the risk of bleeding from the ulcer, as well as to reduce the pain associated with it. Common drugs used in this market include proton pump inhibitors, H2 blockers, and antacids. These drugs are used to reduce the amount of acid produced in the stomach, which can help to reduce the risk of bleeding. Some companies in the Peptic Ulcer Hemorrhage Drug market include Pfizer, GlaxoSmithKline, AstraZeneca, Merck, and Novartis. These companies produce a variety of drugs used to treat peptic ulcers, including proton pump inhibitors, H2 blockers, and antacids. Show Less Read more